Lupin announces Patent License Agreement with Abbott


Today Lupin announced that it and its subsidiaries, Lupin Pharmaceuticals, Inc and Lupin Atlantis Holding S.A., have entered into a license agreement with Abbott Laboratories and Laboratoires Fournier S.A. for various Abbott patents for Antara® (Fenofibrate) Capsules. The licensed patents include, collectively, U.S. Patent Nos. 4,895,726; 6,074,670; 6,277,405; 6,589,552; 7,037,529; 7,041,319; 6,596,317; and 6,652,881; and any divisionals, continuations, continuations in part, reissues, reexaminations, and extensions thereof.

[RTT News]

Note: Lupin sued Ranbaxy recently for Antara.

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Daily interesting IP news, Patent case. Bookmark the permalink.

One Response to Lupin announces Patent License Agreement with Abbott

  1. Shyam says:

    Time to go bottom-fishing with Lupin? What is the company upto?

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s